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Abstract
Introduction: Several factors, including diuretic use and sepsis, interfere with the fractional excretion of sodium,
which is used to distinguish transient from persistent acute kidney injury (AKI). These factors do not affect the
fractional excretion of urea (FeUrea). However, there are conflicting data on the diagnostic accuracy of FeUrea.
Methods: We conducted an observational, prospective, multicenter study at three ICUs in university hospitals.
Unselected patients, except those with obstructive AKI, were admitted to the participating ICUs during a six-month
period. Transient AKI was defined as AKI caused by renal hypoperfusion and reversal within three days. The results
are reported as medians (interquartile ranges).
Results: A total of 203 patients were included. According to our definitions, 67 had no AKI, 54 had transient AKI
and 82 had persistent AKI. FeUrea was 39% (28 to 40) in the no-AKI group, 41% (29 to 54) in the transient AKI
group and 32% (22 to 51) in the persistent AKI group (P = 0.12). FeUrea was of little help in distinguishing
transient AKI from persistent AKI, with the area under the receiver operating characteristic curve being 0.59 (95%
confidence interval, 0.49 to 0.70; P = 0.06). Sensitivity was 63% and specificity was 54% with a cutoff of 35%. In the
subgroup of patients receiving diuretics, the results were similar.
Conclusions: FeUrea may be of little help in distinguishing transient AKI from persistent AKI in critically ill patients,
including those receiving diuretic therapy. Additional studies are needed to evaluate alternative markers or
strategies to differentiate transient from persistent AKI.
Keywords: acute kidney failure, ICU, fractional excretion of sodium, acute tubular necrosis, diuretics, sensitivity and
specificity
Introduction
Acute kidney injury (AKI) is common and associated
with high mortality in critically ill patients [1-3]. The
causes of AKI other than urinary tract obstruction are
usually divided into two categories: prerenal causes, in
which low renal perfusion leads to promptly reversible
renal dysfunction, and intrinsic causes with renal tissue
damage and persistent renal dysfunction. Although
pathological studies are lacking, the leading cause of
persistent AKI in critically ill patients is believed to be
acute tubular necrosis (ATN) [4,5]. It is usually assumed
that there is a continuum that leads from prerenal AKI
to ATN [4-6]. Many publications in the fields of internal
medicine, nephrology and critical care still advocate the
use of urinary indices, such as the fractional excretion
of sodium (FeNa), to differentiate transient from persis-
tent AKI [4,5,7-10]. However, diuretic therapy or sepsis
may affect these indices [11-13]. Since urea reabsorption
occurs mainly at the proximal segment of the nephron
and is unaffected by diuretic intake, the fractional excre-
tion of urea (FeUrea) may be more reliable than FeNa
[11,12,14]. Studies evaluating the performance of FeUrea
have produced discordant results [11,12,14]. In addition,
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tically ill patients has been conducted. A recent review
underlined the lack of evidence supporting the use of
usual urinary indices in critically ill patients and in
patients with sepsis [15]. However, distinguishing transi-
ent AKI from persistent AKI can help the clinician to
choose the optimal treatment for critically ill patients.
Our primary objective in this study was to evaluate
the performance of FeUrea as a tool for distinguishing
transient from persistent AKI in a cohort of critically ill
patients. The secondary objectives were to evaluate the
performance of the usual urinary indices in these
patients and to evaluate the performance of the usual
urinary indices and FeUrea in the subgroup of patients
receiving diuretics.
Materials and methods
Patients
The study was approved by the institutional review
board of the French Society for Intensive Care Medicine
(SRLF-CE-07-212), which waived the need for signed
informed consent. Patients and their next of kin were
i n f o r m e d ,h o w e v e r ,a n dn o n er e f u s e dt op a r t i c i p a t e .
Three ICUs in university hospitals participated in the
study between April and September 2008. Patients
admitted to the participating ICUs were included, except
those younger than 18 years of age, pregnant women,
patients receiving dialysis for an underlying chronic kid-
ney disease and patients with evidence of obstructive
renal failure. Patients from whom urine could not be
collected during the first six hours were excluded from
this study.
Protocol
Each patient was assessed during the first 12 hours fol-
lowing ICU admission. Plasma sodium, urea and creati-
nine levels were measured at ICU admission, and urine
was collected over the next six hours.
Definitions
AKI was defined according to the Acute Kidney Injury
Network classification scheme [16] as a serum creatinine
level increase of 26.4 μmol/L or more, a serum creati-
nine increase ≥ 150% from baseline or urine output <
0.5 mL/kg/hour for six hours or more. For patients
whose baseline serum creatinine level was unknown,
this variable was estimated using the Modification of
Diet in Renal Disease (MDRD) formula [16,17].
Transient AKI was defined as AKI (of any stage) with
a cause of renal hypoperfusion (that is, shock; dehydra-
tion; a medication interfering with renal perfusion, such
as angiotensine-converting enzyme inhibitor; and so on)
and recovery within three days. Recovery was defined as
reversal of oliguria (in the absence of diuretics), and/or
a 50% or greater decrease in serum creatinine [18], and/
or return of serum creatinine to the baseline value
(whether measured or estimated using the MDRD for-
mula [16,17]). Persistent AKI was defined as renal dys-
function without recovery within three days. Oliguria
was defined as urine output < 0.5 mL/kg/hour for six
hours or more.
The FeNa percentage was calculated as ([urinary
sodium/serum sodium]/[urinary creatinine/serum creati-
nine]) ×100. The FeUrea percentage was calculated as
([urinary urea/serum urea]/[urinary creatinine/serum
creatinine]) ×100.
The Logistic Organ Dysfunction (LOD) score and the
Simplified Acute Physiology Score version II (SAPS II)
score were calculated at study inclusion [19,20], and the
Knaus scale score was determined to evaluate chronic
health status at ICU admission (A: no limitation of
activity, B: moderate limitation, C: severe limitation, and
D: bedridden or institutionalized) [21]. Sepsis was diag-
nosed using the criteria developed by the American Col-
lege of Chest Physicians/Society of Critical Care
Medicine consensus conference [22]. Individual organ
failure was defined as a LOD score greater than 1 point
for each system except the kidney [19].
Statistical analysis
Patients remaining in the ICU for < 72 hours were sec-
ondarily excluded from the analysis, since they could
not be classified as having transient or persistent AKI
according to our definition. T h er e s u l t sa r er e p o r t e da s
medians and interquartile ranges (IQRs), numbers and
percentages or as means ± standard deviations (SD) to
express the percentage changes. Categorical variables
were compared using Fisher’s exact test, and continuous
variables were compared using the nonparametric Wil-
coxon signed-rank test or the Mann-Whitney U test for
pairwise comparisons. The Friedman test was used to
compare continuous variables across the three groups.
To determine how well FeUrea distinguished transient
from persistent AKI (our primary objective), we plotted
the receiver-operating characteristic (ROC) curves of the
proportion of true positives against the proportion of
false positives, depending on the prediction rule used to
classify patients as having persistent AKI. A 2 × 2 table
was established to determine the sensitivity and specifi-
city of FeUrea in diagnosing persistent AKI. Cutoff
values, defined as threshold values that maximized the
sum of sensitivity and specificity, were determined on
the ROC curves. The positive and negative likelihood
(LH) ratios were computed. The same strategy was used
to assess our secondary objectives, namely, the perfor-
mance of the usual urinary indices in these patients and
the performance of the usual urinary indices and of
FeUrea in the subgroup of patients receiving diuretics.
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persistent AKI, we performed logistic regression analyses
to identify variables significantly associated with persis-
tent AKI measured by the estimated odds ratio (OR)
with the 95% confidence interval (95% CI). Variables
yielding P values < 0.20 in the bivariate analyses were
entered into a backward stepwise logistic regression
model in which persistent AKI was the variable of inter-
est. The covariates were entered into the model with
critical entry and removal P values of 0.2 and 0.1,
respectively. Last, since the performance of FeUrea was
the primary objective of this study, this variable was
forced into the final model. Colinearity and interactions
were tested. The Hosmer-Lemeshow test was used to
check the goodness of fit of the logistic regression.
All tests were two-sided, and P values < 0.05 were
considered statistically significant. Statistical tests were
performed using the SAS version 6.12 software package
(SAS Institute, Cary, NC, USA).
Results
Study population
During the study period, 203 patients with a median age
of 61 years (46 to 73) were included. Their main charac-
teristics are reported in Table 1. According to our defi-
nitions, 67 patients (33%) had no AKI, 54 patients
(26.6%) had transient AKI and 82 patients (40.4%) had
persistent AKI.
At ICU admission, the median SAPS II score was 46
(34 to 60) and the median LOD score was 6 (4 to 9).
Most patients were admitted for medical conditions
(91.1%). The main risk factors for AKI were sepsis
(67.5%), aminoglycoside therapy (20.7%), chronic heart
failure (19.8%), chronic kidney disease (16.3%) and expo-
sure to iodinated contrast agents (8.9%).
At the time of the study, no patient was being treated
with renal replacement therapy (RRT). Forty-five
patients required RRT during their ICU stay, usually
d u r i n gt h ef i r s tt h r e ed a y si nt h eI C U( 4 1o f4 5
patients). Each of the patients requiring RRT during the
first three days in the ICU had persistent AKI, whereas
the remaining four patients had no AKI at ICU admis-
sion and required RRT later during their ICU stay.
Diagnostic performance of FeUrea
Median FeUrea was 37% (26 to 49) overall, 39% (28 to
40) in patients without AKI, 41% (29 to 54) in patients
with transient AKI and 32% (22 to 51) in patients with
persistent AKI (P = 0.12). Figures 1a, b and 1c show the
distributions of FeNa, FeUrea and urine/plasma (U/P)
urea ratios, respectively, in each group.
The area under the ROC curve was 0.59 (95% CI 0.49
to 0.70; P = 0.06) (Figure 2). At the usual cutoff (35%),
FeUrea predicted persistent AKI with 63% sensitivity
and 54% specificity (Table 2), yielding a positive LH of
1.37 and a negative LH of 0.68. In the study population,
the optimal cutoff was 37%. However, the performance
of FeUrea at this cutoff was poor (66% sensitivity and
53% specificity) (Table 2).
Diagnostic performance of other urinary indices
The performance characteristics of classical urinary
indices for detecting persistent AKI are reported in
Table 2, with the usual and optimal cutoffs in the study
population. Performance was best for the U/P urea ratio
( R O Cc u r v ea r e au n d e rt h ec u r v e( A U C )0 . 7 1( 0 . 6 2t o
0.80)) (Figure 2). A U/P urea ratio < 12 had 66% sensi-
tivity and 66% specificity for persistent AKI (positive
LH, 1.94; negative LH, 0.52). When entered into a
regression logistic model, none of these urinary indices
were independently associated with persistent AKI.
Three variables were found to be associated with persis-
tent AKI: chronic kidney disease (OR 11.89, 95% CI 2.52
to 56.24; P = 0.02), need for vasopressors at ICU admis-
sion (OR 2.60, 95% CI 1.15 to 5.91) and oliguria at ICU
admission (OR 2.50, 95% CI 1.11 to 5.63). The model
had good calibration (goodness of fit P =0 . 8 8 ) .F e U r e a
was then forced into the final model and was not
selected.
Diagnostic performance of urinary indices in patients
undergoing diuretic therapy
Overall, 67 patients (33%) received diuretics before or at
I C Ua d m i s s i o n .A m o n gt h e m ,1 7h a dn oA K I( 2 5 . 4 %o f
patients without AKI), 18 had transient AKI (33.3% of
patients with transient AKI) and 32 had persistent AKI
(39% of patients with persistent AKI). The performance
characteristics of urinary indices in patients undergoing
diuretic therapy are reported in Table 2. As with the
overall population, the performance of FeUrea in this
patient subgroup was poor (ROC curve AUC 0.58 (0.41
to 0.75)). The U/P urea ratio performed satisfactorily in
differentiating transient from persistent AKI (ROC curve
AUC 0.82 (0.70 to 0.94)). With a U/P urea ratio cutoff
of 10, sensitivity was 72%, specificity was 69%, positive
LH was 2.32 and negative LH was 0.41.
Diagnostic performance of urinary indices in patients
with sepsis at ICU admission
Overall, 137 patients (67%) had sepsis at ICU admission.
Among them, 43 had no AKI (64.2% of patients without
AKI), 33 had transient AKI (61.1% of patients with tran-
sient AKI) and 61 had persistent AKI (74.4% of patients
with persistent AKI). The performance characteristics of
urinary indices in patients with sepsis are reported in
Table 2. As with the overall population, the performance
of FeUrea in this patient subgroup was poor (ROC curve
AUC 0.56 (0.43 to 0.68)). The performance of other
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Page 3 of 8Table 1 Characteristics of patients without AKI, with transient AKI and with persistent AKI
a
Demographics No AKI (n = 67) Transient AKI (n = 54) Persistent AKI (n = 82) P value
b
Patient characteristics
Male gender 34 (50.7%) 32 (59.3%) 56 (68.3%) 0.15
Age, years 50 (40 to 60) 71 (49 to 76) 66 (56 to 74) < 0.0001
Weight, kg 68 (57 to 85) 75 (64 to 85) 80 (68 to 89) 0.006
Knaus score C or D [21] 21 (31.3%) 21 (38.9%) 40 (48.8%) 0.09
LOD score at ICU admission [19] 4 (2 to 7) 6 (5 to 9) 8 (5 to 9) < 0.0001
SAPS II score at ICU admission [20] 35 (27 to 47) 50 (39 to 62) 52 (39 to 62) < 0.0001
Risk factors for AKI
Chronic heart failure 8 (11.9%) 14 (26.4%) 18 (22.0%) 0.15
Chronic kidney disease
c 1 (1.5%) 3 (5.6%) 23 (28.0%) < 0.0001
Sepsis 43 (64.2%) 33 (61.1%) 61 (74.4%) 0.12
Aminoglycosides 8 (11.9%) 9 (16.7%) 25 (30.5%) 0.2
Ionidated contrast agents 6 (9.0%) 3 (5.6%) 9 (11.0%) 0.55
Organ failure at ICU admission
Medical condition 62 (92.5%) 51 (94.4%) 72 (87.8%) 0.36
Acute respiratory failure 54 (80.6%) 39 (72.2%) 61 (74.4%) 0.51
Coma 22 (32.8%) 24 (44.4%) 29 (35.4%) 0.34
Shock 22 (32.8%) 28 (51.9%) 43 (52.4%) 0.03
Treatments in the ICU
Need for vasoactive drugs 20 (29.9%) 23 (42.6%) 43 (52.4%) 0.02
Mechanical ventilation 43 (64.2%) 34 (63.0%) 52 (63.4%) 0.99
Noninvasive mechanical ventilation 21 (31.3%) 14 (25.9%) 21 (25.6%) 0.73
Renal replacement therapy 4 (6.0%) 0 41 (50.0%) < 0.0001
Diuretics (at admission) 17 (25.4%) 18 (33.3%) 32 (39.0%) 0.21
Renal function at admission
Diuresis, mL/kg/hour
d 0.69 (0.59 to 0.99) 0.45 (0.32 to 1.11) 0.40 (0.21 to 0.72) < 0.0001
Plasma urea, mmol/L 5.4 (3.4 to 7.9) 13.1 (6.8 to 17.3) 17.4 (10.9 to 25.1) < 0.0001
Serum creatinine, μmol/L 68 (59 to 78) 124 (98 to 164) 220 (138 to 360) < 0.0001
Urinary indices
Urine Na
+/urine K
+ 1.8 (0.35 to 1.75) 1.0 (0.4 to 1.8) 1.3 (0.5 to 2.4) 0.01
FeNa, % 0.5 (0.3 to 1.3) 0.5 (0.2 to 1.3) 0.8 (0.4 to 4.0) 0.004
FeUrea, % 39 (28 to 40) 41 (29 to 54) 32 (22 to 51) 0.12
U/P urea 30 (19 to 39) 16 (9 to 25) 7 (4 to 14) < 0.0001
U/P creatinine 83 (52 to 127) 47 (25 to 76) 30 (11 to 58) < 0.0001
Outcomes
ICU mortality 7 (11.7%) 13 (25%) 37 (48.1%) 0.0002
Hospital mortality 14 (20.9%) 15 (27.8%) 42 (51.2%) 0.0003
aAKI: acute kidney injury; LOD: Logistic Organ Dysfunction score, which can range from 0 to 22; SAPS II: Simplified Acute Physiology Score version II; FeNa,
fractional excretion of sodium ([urine sodium/serum sodium]/[urine creatinine/serum creatinine]) ×100; FeUrea, fractional excretion of urea ([urine urea/serum
urea]/[urine creatinine/serum creatinine]) ×100; U/P urea, urine urea/plasma urea; U/P creatinine, urine creatinine/serum creatinine. Data are medians (IQR) or
number of patients (%).
bP values represent comparisons across the three patient groups.
cChronic renal failure was defined as creatinine clearance < 60 mL/
minute before ICU admission.
dDiuresis represents diuresis per kilogram and per hour during the first six hours following inclusion
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Figure 1 (a) Boxplot of the fractional excretion of sodium (FeNa) in the overall study population according to renal function.T h e
dotted line represents FeNa of 1% (P = 0.04). (b) Boxplot of the fractional excretion of urea (FeUrea) in the overall study population according
to renal function. The dotted line represents FeUrea of 35% (P = 0.12). (c) Boxplot of the urine/plasma (U/P) urea ratio in the overall study
population according to renal function. The dotted line represents a U/P urea ratio of 10 (P < 0.0001).
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Figure 2 Receiver-operating characteristic (ROC) curve depicting the ability of the fractional excretion of urea (FeUrea) and urine/
plasma (U/P) urea ratio to detect persistent AKI in the subgroup of patients with AKI. The ROC curve shows the relationship between the
proportion of true positives (Sensitivity) and the proportion of false positives (1-Specificity) with various FeUrea and U/P urea ratio cutoffs.
Diagonal segments are produced by ties. The area under the ROC curve is 0.59 (95% confidence interval, 0.49 to 0.70; P = 0.06) for FeUrea. The
area under the ROC curve is 0.71 (95% confidence interval, 0.62 to 0.80; P = 0.04) for U/P urea ratio.
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Page 5 of 8urinary indices was similar to that in the overall patient
population.
Discussion
In critically ill patients, FeUrea was not helpful in differ-
entiating transient AKI from persistent AKI. Both in the
overall population and in the subgroup of patients
receiving diuretics, FeUrea performed less well than
FeNa or the U/P urea ratio.
There is little scientific evidence to support the use of
FeUrea. Only three studies have evaluated the accuracy
of FeUrea in distinguishing transient from persistent
AKI [11,12,14]. Their results are conflicting. In one
study, FeUrea was 90% sensitive and 96% specific in dif-
ferentiating transient from persistent AKI when a cutoff
of 35% was used [11]. Conversely, another study found
very poor diagnostic accuracy of FeUrea [12]. Several
factors may explain these discordant results. First, these
studies were single-center cohort studies and included
only patients who were referred to nephrologists [11,12].
In addition, the study populations were poorly described
but include both critically ill patients and patients in
wards. Therefore, selection bias and differences between
the institutions and study populations may explain the
discrepancies [11,12]. Furthermore, FeUrea reflects the
ratio of urea clearance over creatinine clearance ratio.
Variations in creatinine clearance may therefore modify
FeUrea. In the study that found good performance of
FeUrea [11,12], wide differences in creatinine clearance
can be suspected between patients with transient AKI
and those with persistent AKI: serum creatinine levels
were 140 ± 22 μmol/L and 520 ± 22 μmol/L (means +/-
SD) in these two groups, respectively.
Interestingly, the performance of urinary indices in
our study was poor. Several factors may explain this
finding. First, although many publications have advo-
cated the use of urinary biochemistry indices to differ-
entiate transient from persistent AKI, these indices have
not been extensively studied in critically ill patients or
in patients with sepsis [4,5,23]. The few published
Table 2 Performance of usual urinary markers for detecting patients with persistent AKI among patients with AKI,
with the usual and optimal (*) cutoff values
a
Patient groups FeNa
>1 %
FeNa*
> 0.58%
FeUrea
< 35%
FeUrea*
< 37%
U/P urea
<1 0
U/P urea* < 12 U/P creat < 20 U/P creat* < 12
All patients with AKI (n = 136; persistent AKI prevalence = 60.3%)
Sensitivity (%) 0.48 0.63 0.63 0.66 0.74 0.66 0.79 0.59
Specificity (%) 0.7 0.61 0.54 0.53 0.57 0.66 0.39 0.59
Positive predictive value 0.71 0.71 0.67 0.68 0.72 0.74 0.66 0.68
Negative predictive value 0.47 0.47 0.47 0.51 0.59 0.56 0.55 0.48
Positive likelihood ratio 1.6 1.61 1.37 1.4 1.72 1.94 1.3 1.44
Negative likelihood ratio 0.74 0.61 0.68 0.64 0.45 0.52 0.54 0.69
Younden’s index 0.18 0.24 0.17 0.19 0.31 0.32 0.18 0.18
ROC AUC 0.62 (0.52 to 0.72) 0.59 (0.49 to 0.70) 0.71 (0.62 to 0.80) 0.62 (0.53 to 0.72)
Patients taking diuretics (n = 50; persistent AKI prevalence = 64%)
Sensitivity (%) 0.75 0.62 0.61 0.61 0.72 0.61 0.78 0.89
Specificity (%) 0.56 0.56 0.47 0.59 0.69 0.75 0.5 0.38
Positive predictive value 0.71 0.71 0.67 0.68 0.81 0.81 0.73 0.72
Negative predictive value 0.47 0.47 0.49 0.51 0.58 0.52 0.56 0.66
Positive likelihood ratio 1.7 1.41 1.15 1.49 2.32 2.44 1.56 1.44
Negative likelihood ratio 0.47 0.68 0.83 0.66 0.41 0.52 0.44 0.29
Younden’s index 0.31 0.18 0.08 0.2 0.41 0.36 0.28 0.27
ROC AUC 0.69 (0.54 to 0.81) 0.58 (0.41 to 0.75) 0.82 (0.70 to 0.94) 0.71 (0.56 to 0.86)
Patients with sepsis (n = 94; persistent AKI prevalence = 65%)
Sensitivity (%) 0.5 0.65 0.63 0.63 0.8 0.67 0.87 0.93
Specificity (%) 0.86 0.56 0.52 0.57 0.63 0.63 0.42 0.37
Positive predictive value 0.87 0.73 0.71 0.73 0.8 0.63 0.74 0.73
Negative predictive value 0.48 0.46 0.43 0.45 0.63 0.51 0.63 0.74
Positive likelihood ratio 3.57 1.48 1.31 1.47 2.1 1.81 1.5 1.48
Negative likelihood ratio 0.58 0.63 0.71 0.65 0.32 0.52 0.31 0.19
Younden’s index 0.36 0.19 0.15 0.2 0.43 0.3 0.29 0.3
ROC AUC 0.67 (0.56 to 0.79) 0.56 (0.43 to 0.68) 0.71 (0.60 to 0.82) 0.65 (0.53 to 0.77)
aAKI: acute kidney injury; ROC: receiver operating characteristic; AUC: area under the curve.
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Page 6 of 8studies have had several limitations: most of them were
single-center case series or retrospective studies, the
definition of AKI varied across the studies and the defi-
nition of transient AKI also varied, being subjective in
most instances [24-30]. Several of these studies included
patients who did not have critical illnesses [11,12,28]. In
addition, we chose a definition allowing for a distinction
between transient and persistent AKI. Our study was
therefore not designed to evaluate the interest of these
indices in distinguishing prerenal and intrinsic AKI.
This point may partly explain the poor performance of
the urinary indices in our study. Last, most of the stu-
died patients had sepsis or shock at ICU admission.
This condition is frequently associated with renal hand-
ling of sodium or water independently of an underlying
AKI. This may also explain the poor performance of
these indices in the studied population. Nevertheless,
taking these factors into account, and although the
usual urinary indices were able to differentiate transient
from persistent AKI, the accuracy of the indices was
poor and none of them were independently associated
with the diagnosis of persistent AKI, indicating a need
to identify other biomarkers.
Our study has several limitations. First, our definition
of transient AKI was mainly based on renal function
recovery. Indeed, an accurate definition of prerenal AKI
would have required a highly subjective definition based
on clinical histories, physical examinations and physi-
cians’ judgments [11,15]. In addition, AKI is mainly due
to sepsis in critically ill patients, and in this setting there
is frequently a continuum between volume depletion and
persistent kidney injuries rather than two distinct entities,
with the two mechanisms being frequently associated.
Therefore, we chose a definition that relies only on an
objective criterion. This point needs to be taken into
account to interpret our findings. In the same way, the
course of kidney function may have been modified by
factors following study inclusion. However, in the ICU
setting, predicting which patients will have persistent
AKI may help to optimize treatment, such as by promptly
restoring renal perfusion, limiting fluids or starting RRT.
Our definition was highly sensitive for detecting patients
with transient AKI (none of the patients in this group
required RRT) but lacked specificity, since only 50% of
patients in the persistent AKI group required RRT. Addi-
tional studies may help to determine the definition that
best matches the need for RRT.
Second, although renal function was assessed within a
few hours after ICU admission, the time course of the
urinary indices was not evaluated. FeNa is known to
vary during the first 12 to 24 hours in critically ill
patients [13,30]. Few data are available on the time
course of other urinary indices [13]. Any variations
might explain the poor performance of FeNa or the
other urinary indices. Therefore, these variations need
to be investigated to determine the optimal time for
renal assessment in critically ill patients.
Last, few of our patients received diuretics. The poor
performance of urinary indices in this subgroup may
therefore be related to low statistical power.
Conclusions
In summary, we found that FeUrea and the usual urin-
ary indices performed poorly in separating transient
from persistent AKI in an unselected population of criti-
cally ill patients. Additional studies are needed to evalu-
ate alternative markers of renal injury or strategies for
differentiating transient from persistent AKI.
Key messages
￿ FeUrea performed poorly in separating transient
from persistent AKI in critically ill patients.
￿ Although the usual urinary indices (FeNa, U/P
urea ratio or U/P creatinine ratio) are able to differ-
entiate transient from persistent AKI, their accuracy
remains poor in this setting.
￿ The high incidence of situations that may induce
renal handling of water or sodium (that is, sepsis or
shock) may explain the poor performance of urinary
indices in this setting.
￿ Additional studies are needed to evaluate alterna-
tive markers of renal injury or strategies for differen-
tiating transient from persistent AKI.
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